Thomas S. Rush
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Hemoglobin structure and function, Peptidase Inhibition and Analysis, Protease and Inhibitor Mechanisms, Porphyrin and Phthalocyanine Chemistry, Protein Structure and Dynamics
Most-Cited Works
- → Rethinking drug design in the artificial intelligence era(2019)823 cited
- → A Shape-Based 3-D Scaffold Hopping Method and Its Application to a Bacterial Protein−Protein Interaction(2005)601 cited
- → Functional, Biophysical, and Structural Bases for Antibacterial Activity of Tigecycline(2006)201 cited
- → Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors(2018)146 cited
- → Computational Modeling of Metalloporphyrin Structure and Vibrational Spectra: Porphyrin Ruffling in NiTPP(2000)139 cited
- → Ab initio calculations of the ultraviolet resonance Raman spectra of uracil(1995)114 cited
- → Potent, selective, and orally bioavailable matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis(2005)107 cited
- → DFT-SQM Force Field for Nickel Porphine: Intrinsic Ruffling(1999)102 cited
- → Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design(2006)91 cited
- → The Role of Helix 1 Aspartates and Salt Bridges in the Stability and Conversion of Prion Protein(2003)87 cited